Stem Cell Therapy in Incurable Neurological Disorders

Neurogen Brain and Spine Institute

Status and phase: Withdrawn; Phase 1

Conditions: Neurological; Disorder, Nervous System

Treatments: Biological: Stem Cell

Study type: Interventional

Funder types: Other

Identifiers

NCT02245776

NGBSI-16

Details and patient eligibility

About

The purpose of the study was to analyze the benefit of autologous mononuclear cell therapy in incurable neurological disorders.

Sex: All

Ages: 6 months to 80 years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• diagnosed cases of incurable neurological disorders
• age above 6 months

Exclusion criteria

• presence of acute infections such as Human immunodeficiency virus/Hepatitis B Virus/Hepatitis C Virus
• malignancies
• bleeding tendencies
• pneumonia
• renal failure
• severe liver dysfunction
• severe anemia [Hemoglobin < 8]
• any bone marrow disorder
• space occupying lesion in brain
• other acute medical conditions such as respiratory infection and pyrexia
• pregnancy
• lactation

Trial design

Primary purpose: Treatment

Allocation: N/A

Interventional model: Single Group Assignment

Masking: None (Open label)

---

0 participants in 1 patient group

Stem Cell

Experimental group

Description:

Bone marrow mononuclear cell transplantation

Treatment:

Biological: Stem Cell